- Home
- KWE vs SHPH Comparison
KWE vs SHPH Comparison
Compare KWE & SHPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KWE
- SHPH
- Stock Information
- Founded
- KWE 2017
- SHPH 2012
- Country
- KWE Canada
- SHPH United States
- Employees
- KWE N/A
- SHPH N/A
- Industry
- KWE
- SHPH Biotechnology: Pharmaceutical Preparations
- Sector
- KWE
- SHPH Health Care
- Exchange
- KWE Nasdaq
- SHPH Nasdaq
- Market Cap
- KWE 2.3M
- SHPH 2.3M
- IPO Year
- KWE N/A
- SHPH 2022
- Fundamental
- Price
- KWE $5.80
- SHPH $0.18
- Analyst Decision
- KWE
- SHPH
- Analyst Count
- KWE 0
- SHPH 0
- Target Price
- KWE N/A
- SHPH N/A
- AVG Volume (30 Days)
- KWE 89.8K
- SHPH 12.3M
- Earning Date
- KWE 05-16-2025
- SHPH 05-08-2025
- Dividend Yield
- KWE N/A
- SHPH N/A
- EPS Growth
- KWE N/A
- SHPH N/A
- EPS
- KWE N/A
- SHPH N/A
- Revenue
- KWE $2,115,849.00
- SHPH N/A
- Revenue This Year
- KWE N/A
- SHPH N/A
- Revenue Next Year
- KWE N/A
- SHPH N/A
- P/E Ratio
- KWE N/A
- SHPH N/A
- Revenue Growth
- KWE 121.88
- SHPH N/A
- 52 Week Low
- KWE $3.86
- SHPH $0.16
- 52 Week High
- KWE $243.60
- SHPH $4.30
- Technical
- Relative Strength Index (RSI)
- KWE 55.89
- SHPH 38.08
- Support Level
- KWE $4.89
- SHPH $0.16
- Resistance Level
- KWE $5.90
- SHPH $0.19
- Average True Range (ATR)
- KWE 0.43
- SHPH 0.02
- MACD
- KWE 0.07
- SHPH 0.01
- Stochastic Oscillator
- KWE 65.47
- SHPH 38.80
About KWE KWESST Micro Systems Inc.
KWESST Micro Systems Inc develops and commercializes next-generation tactical systems. The company offers breakthrough technology in lethal and non-lethal systems with broad application, including law enforcement and personal defence, modernized digitization of tactical forces for shared situational awareness and targeting, and counter-measures against threats such as drones, lasers and electronic detection.
About SHPH Shuttle Pharmaceuticals Holdings Inc.
Shuttle Pharmaceuticals Holdings Inc is a clinical-stage pharmaceutical company leveraging its proprietary technology to develop novel therapies designed to cure cancers. The company's goal is to extend the benefits of cancer treatments with surgery, radiation therapy, chemotherapy and immunotherapy. Radiation therapy (RT) is one of the effective modalities for treating cancers. It is developing a pipeline of products designed to address the limitations of the current cancer therapies as well as to extend to the new applications of RT. The company believes that its product candidates will enable the company to deliver cancer treatments that are safer, more reliable and at a greater scale than that of the current standard of care.